📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

NH-sulfoximine: A novel pharmacological inhibitor of the mitochondrial F1 Fo -ATPase, which suppresses viability of cancerous cells. (2021)

First Author: Strobbe D

Attributed to: The Resilient Brain. Imaging Biomarkers of Brain Metabolic Reserve funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.15279

PubMed Identifier: 33037618

Publication URI: http://europepmc.org/abstract/MED/33037618

Type: Journal Article/Review

Volume: 178

Parent Publication: British journal of pharmacology

Issue: 2

ISSN: 0007-1188